Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Dermatology ; 217(4): 340-2, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18799880

RESUMO

We report the case of a man who presented cutaneous aseptic abscesses, a rare form of neutrophilic disease, associated with Yersinia enterocolitica infection and who was later diagnosed as having Crohn's disease (CD). Genetic analysis showed that the patient had a mutation in the caspase activation recruitment domain 15/nucleotide oligomerization domain 2 gene (R702W heterozygote). This case is in keeping with recent evidence in the literature which suggests that CD is a disease linked to abnormal immune responses to enteric bacteria in genetically susceptible individuals. Further understanding of the innate immune system should provide new insights into the pathogenesis of these inflammatory diseases.


Assuntos
Abscesso/etiologia , Colite Ulcerativa/imunologia , Doença de Crohn/imunologia , Síndrome de Sweet/complicações , Yersiniose/complicações , Yersinia enterocolitica , Abscesso/diagnóstico , Abscesso/tratamento farmacológico , Adulto , Caspases/genética , Colite Ulcerativa/diagnóstico , Colite Ulcerativa/tratamento farmacológico , Colite Ulcerativa/genética , Doença de Crohn/diagnóstico , Doença de Crohn/tratamento farmacológico , Doença de Crohn/genética , Glucocorticoides/uso terapêutico , Humanos , Perna (Membro) , Masculino , Mutação , Proteína Adaptadora de Sinalização NOD2/genética , Fenótipo , Polimorfismo Genético , Síndrome de Sweet/diagnóstico , Síndrome de Sweet/tratamento farmacológico , Resultado do Tratamento , Yersiniose/diagnóstico , Yersiniose/tratamento farmacológico , Yersinia enterocolitica/isolamento & purificação
2.
Ann Dermatol Venereol ; 134(6-7): 535-40, 2007.
Artigo em Francês | MEDLINE | ID: mdl-17657179

RESUMO

BACKGROUND: We examined whether serum values for proteins S100B and MIA could allow early and reliable screening of metastatic growth in melanoma. PATIENTS AND METHODS: We carried out a prospective study from 1998 to 2005 in patients presenting non-metastatic melanomas with a Breslow score>0.75 mm. Four PS00B and MIA measurements per patient were performed at regular intervals over 1 to 2 years. Blood samples were analysed for PS100B and MIA using an ELISA technique. RESULTS: Fifty patients were analysed. The maximum interval between collection of samples was 8 months. Metastatic development was noted in 15 patients. Where melanoma progressed to stage III, sensitivity was 33% for PS100B and 25% for MIA. Where it progressed to stage IV, sensitivity was 50% for PS100B and 30% for MIA. A rise in these values preceded discovery of metastasis in 3 cases for PS100B and of MIA in 1 case. Specificity of the assays was 100% for PS100B and 91% for MIA. DISCUSSION: Sensitivity and specificity were better for PS100B than for MIA regarding detection of metastasis during follow-up of thick melanomas. The ELISA technique used in our study seemed to increase the specificity of the assay but not its sensitivity compared to other techniques used previously. We may thus confirm the benefits of PS100B assay for early detection of metastasis in melanomas. However, this laboratory surveillance method is not an acceptable substitute for regular clinical follow-up due to its low sensitivity.


Assuntos
Biomarcadores Tumorais/sangue , Proteínas da Matriz Extracelular/sangue , Melanoma/sangue , Melanoma/secundário , Proteínas de Neoplasias/sangue , Proteínas S100/sangue , Neoplasias Cutâneas/sangue , Neoplasias Cutâneas/patologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Diagnóstico Precoce , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Masculino , Melanoma/diagnóstico , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Estudos Prospectivos , Sensibilidade e Especificidade , Neoplasias Cutâneas/diagnóstico
3.
Arch Pediatr ; 13(2): 149-51, 2006 Feb.
Artigo em Francês | MEDLINE | ID: mdl-16337113

RESUMO

UNLABELLED: In children, chronic cervicofacial ulceration related to dental infection is rare. Thus the diagnosis is often late and the treatment is consequently delayed. We report 2 new cases. CASES REPORT: A 13-year-old boy presented with a 1-year history of chronic and suppurative ulceration on the right cheek. Culture was positive for actinomycetes. In spite of a prolonged and miscellaneous antibiotherapy, the lesion recured. The ulceration healed after the eradication of infection on a right superior molar. A 12-year-old girl presented with a right sub-mandibular ulceration, which appeared 3 months before. This lesion did not respond to penicillinotherapy given during 3 months. An infection on a right inferior molar was diagnosed on a tomodensitometry. 3 months after the tooth extraction, the ulceration healed without recurrence. CONCLUSION: These cases emphasize the interest to look for a dental infection at the origin of chronic cervicofacial lesion.


Assuntos
Actinobacteria/isolamento & purificação , Infecção Focal Dentária/complicações , Infecções por Bactérias Gram-Positivas/diagnóstico , Doenças Mandibulares/microbiologia , Úlcera Cutânea/microbiologia , Adolescente , Bochecha , Criança , Feminino , Infecção Focal Dentária/diagnóstico , Humanos , Masculino , Recidiva
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA